In a separate screen of 34 SCLC cell lines, four structurally diverse Aurora kinase inhibitors VX680, alisertib, PHA680632, and ZM447439 were most effective against the MYC-amplified cell lines (37). The gene discussed is MYC; the disease is small cell lung carcinoma.